{"id":"https://openalex.org/W2264421545","doi":"https://doi.org/10.3233/978-1-61499-589-0-88","title":"Predicting Adverse Drug Events with Confidence","display_name":"Predicting Adverse Drug Events with Confidence","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2264421545","doi":"https://doi.org/10.3233/978-1-61499-589-0-88","mag":"2264421545"},"language":"en","primary_location":{"id":"doi:10.3233/978-1-61499-589-0-88","is_oa":false,"landing_page_url":"https://doi.org/10.3233/978-1-61499-589-0-88","pdf_url":null,"source":{"id":"https://openalex.org/S4210201731","display_name":"Frontiers in artificial intelligence and applications","issn_l":"0922-6389","issn":["0922-6389","1879-8314"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Artificial Intelligence and Applications","raw_type":"book-chapter"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Löfström Tuve","orcid":null},"institutions":[{"id":"https://openalex.org/I992397","display_name":"University of Bor\u00e5s","ror":"https://ror.org/01fdxwh83","country_code":"SE","type":"education","lineage":["https://openalex.org/I992397"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Löfström Tuve","raw_affiliation_strings":["University of Bor\u00e5s, Bor\u00e5s, Sweden"],"affiliations":[{"raw_affiliation_string":"University of Bor\u00e5s, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I992397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100623271","display_name":"Jing Zhao","orcid":"https://orcid.org/0000-0002-0737-6532"},"institutions":[{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Zhao Jing","raw_affiliation_strings":["Stockholm University, Stockholm, Sweden"],"affiliations":[{"raw_affiliation_string":"Stockholm University, Stockholm, Sweden","institution_ids":["https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059387263","display_name":"Henrik Linusson","orcid":null},"institutions":[{"id":"https://openalex.org/I992397","display_name":"University of Bor\u00e5s","ror":"https://ror.org/01fdxwh83","country_code":"SE","type":"education","lineage":["https://openalex.org/I992397"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Linusson Henrik","raw_affiliation_strings":["University of Bor\u00e5s, Bor\u00e5s, Sweden"],"affiliations":[{"raw_affiliation_string":"University of Bor\u00e5s, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I992397"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023208169","display_name":"Karl Jansson","orcid":null},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jansson Karl","raw_affiliation_strings":[],"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I992397"],"apc_list":null,"apc_paid":null,"fwci":1.5398,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.83236994,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.982699990272522,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.982699990272522,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug","display_name":"Drug","score":0.5623539686203003},{"id":"https://openalex.org/keywords/adverse-effect","display_name":"Adverse effect","score":0.5589750409126282},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.4414726495742798},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.33156031370162964},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.28651517629623413}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5623539686203003},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5589750409126282},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4414726495742798},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33156031370162964},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28651517629623413}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3233/978-1-61499-589-0-88","is_oa":false,"landing_page_url":"https://doi.org/10.3233/978-1-61499-589-0-88","pdf_url":null,"source":{"id":"https://openalex.org/S4210201731","display_name":"Frontiers in artificial intelligence and applications","issn_l":"0922-6389","issn":["0922-6389","1879-8314"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Artificial Intelligence and Applications","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725"],"abstract_inverted_index":{"This":[0,77],"study":[1],"introduces":[2],"the":[3,8,12,34],"conformal":[4,51,75],"prediction":[5],"framework":[6],"to":[7,81,84],"task":[9],"of":[10,14,26,33,50],"predicting":[11],"presence":[13],"adverse":[15],"drug":[16],"events":[17],"in":[18],"electronic":[19],"health":[20],"records":[21],"with":[22],"an":[23],"associated":[24],"measure":[25],"statistically":[27],"valid":[28],"confidence.":[29],"The":[30],"imbalanced":[31],"nature":[32],"problem":[35],"was":[36,56],"addressed":[37],"both":[38],"by":[39,46],"evaluating":[40],"different":[41,48,60],"machine":[42],"learning":[43],"algorithms,":[44],"and":[45],"comparing":[47],"types":[49],"predictors.":[52],"A":[53],"novel":[54,78],"solution":[55,79],"also":[57],"evaluated,":[58],"where":[59],"underlying":[61],"models,":[62],"each":[63],"model":[64],"optimized":[65],"towards":[66],"one":[67],"particular":[68],"class,":[69],"were":[70],"combined":[71],"into":[72],"a":[73],"single":[74],"predictor.":[76],"proved":[80],"be":[82],"superior":[83],"previously":[85],"existing":[86],"approaches.":[87]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-04-16T08:26:57.006410","created_date":"2016-06-24T00:00:00"}